Cytokinetics
CYTK
CYTK
250 hedge funds and large institutions have $3.22B invested in Cytokinetics in 2023 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 94 increasing their positions, 78 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% less funds holding
Funds holding: 252 → 250 (-2)
9% less capital invested
Capital invested by funds: $3.55B → $3.22B (-$329M)
48% less call options, than puts
Call options by funds: $29.8M | Put options by funds: $57.1M
Holders
250
Holding in Top 10
10
Calls
$29.8M
Puts
$57.1M
Top Buyers
| 1 | +$37.7M | |
| 2 | +$13.9M | |
| 3 | +$12.6M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$11.7M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$9.78M |
Top Sellers
| 1 | -$32.1M | |
| 2 | -$14.7M | |
| 3 | -$11.8M | |
| 4 |
Goldman Sachs
New York
|
-$11.7M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$9.41M |